Lyell Immunopharma | SC 13G/A:超過5%持股股東披露文件(修正)-The Vanguard Group(3.93%)
Lyell Immunopharma | SC 13G/A:超過5%持股股東披露文件(修正)-The Vanguard Group(3.93%)
Lyell Immunopharma | 3:首次持股聲明-董事 Ramachandra Sumant
Lyell Immunopharma | 4:持股變動聲明-董事 Ramachandra Sumant
Lyell Immunopharma | SC 13G:超過5%持股股東披露文件-James Tananbaum (“Tananbaum”)(5.3%),Foresite Capital Fund IV, L.P. (“FCF IV”)(3.2%)等
Lyell Immunopharma | 4:持股變動聲明-董事 NELSEN ROBERT
Lyell Immunopharma | 4:持股變動聲明-董事 Klausner Richard
Lyell Immunopharma | 4:持股變動聲明-董事 Bishop Hans Edgar
Lyell Immunopharma | 4:持股變動聲明-董事 RIEFLIN WILLIAM JL
Lyell Immunopharma | 4:持股變動聲明-董事 NABEL ELIZABETH G
Lyell Immunopharma | 4:持股變動聲明-董事 BRAWLEY OTIS W
Lyell Immunopharma | 4:持股變動聲明-董事 FRIEDMAN CATHY
Lyell Immunopharma | SC 13G/A:超過5%持股股東披露文件(修正)-ARCH Venture Fund IX, L.P.(14.5%),ARCH Venture Fund IX Overage, L.P.(14.5%)等
Lyell Immunopharma | 4:持股變動聲明-高管 Lang Matthew
Lyell Immunopharma | 4:持股變動聲明-高管 Hill Stephen J.
Lyell Immunopharma | 4:持股變動聲明-高管 Lee Gary K.
Lyell Immunopharma | 4:持股變動聲明-高管 Newton Charles W.
Lyell Immunopharma | 4:持股變動聲明-高管 Seely Lynn
Lyell Immunopharma | SC 13G/A:超過5%持股股東披露文件(修正)-The Vanguard Group(5.40%)
Lyell Immunopharma | SC 13G:超過5%持股股東披露文件-BlackRock, Inc.(5.7%)
暫無數據
暫無數據